sr141716 has been researched along with Cirrhoses, Experimental Liver in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, M; Caraceni, P; Croci, T; Domenicali, M; Giannone, F; Pertosa, AM; Principe, A; Trevisani, F; Zambruni, A | 1 |
| Baldassarre, M; Bernardi, M; Caraceni, P; Domenicali, M; Giannone, FA; Trevisani, F; Zaccherini, G | 1 |
| Senior, K | 1 |
| Arroyo, V; Cejudo-Martín, P; Clària, J; Fernández-Varo, G; Jiménez, W; Martín-Ruiz, R; Planagumà, A; Rivera, F; Rodés, J; Ros, J; To-Figueras, J | 1 |
4 other study(ies) available for sr141716 and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
Topics: Animals; Ascites; Blood Pressure; Carbon Tetrachloride; Cardiac Output; Diuresis; Dose-Response Relationship, Drug; Kidney; Liver Cirrhosis, Experimental; Male; Natriuresis; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Renal Circulation; Rimonabant; Sodium; Sodium, Dietary; Time Factors; Vascular Resistance | 2009 |
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.
Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Evaluation, Preclinical; Extracellular Matrix; Hepatic Stellate Cells; Liver Cirrhosis, Experimental; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Remission Induction; Rimonabant | 2012 |
Endogenously produced cannabinoids and liver cirrhosis.
Topics: Animals; Arachidonic Acids; Cannabinoids; Endocannabinoids; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Piperidines; Polyunsaturated Alkamides; Portal Pressure; Pyrazoles; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vasodilation | 2001 |
Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.
Topics: Animals; Arachidonic Acids; Blood Pressure; Cannabinoids; Endocannabinoids; Enzyme Inhibitors; Homeostasis; Liver Cirrhosis, Experimental; Male; Monocytes; NG-Nitroarginine Methyl Ester; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vascular Resistance | 2002 |